Upgrade to SI Premium - Free Trial

Catalent (CTLT) PT Lowered to $81 at Morgan Stanley But Sees Long-Term Entry Point

November 2, 2022 1:06 PM
Morgan Stanley analyst Tejas Savant lowered the price target on Catalent (NYSE: CTLT) to $81.00 (from $120.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles